2018
DOI: 10.1080/00016489.2018.1497806
|View full text |Cite
|
Sign up to set email alerts
|

eNOS gene Glu298Asp variant confer risk in sudden sensorineural hearing loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Therefore, inhibition of NOS3 can reduce the synthesis of NO to protect hearing. Moreover, eNOS3 gene evidently participates in microvascular damage in sudden sensorineural hearing loss patients [39]. The survival of inner cells is associated with blood ow and vascular lesions, and activation of the ROS/PI3K/AKT/eNOS signaling pathway at the early stage confers protection against apoptosis due to high glucose levels in vascular endothelial cells [40].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, inhibition of NOS3 can reduce the synthesis of NO to protect hearing. Moreover, eNOS3 gene evidently participates in microvascular damage in sudden sensorineural hearing loss patients [39]. The survival of inner cells is associated with blood ow and vascular lesions, and activation of the ROS/PI3K/AKT/eNOS signaling pathway at the early stage confers protection against apoptosis due to high glucose levels in vascular endothelial cells [40].…”
Section: Discussionmentioning
confidence: 99%
“…28 Data in the current literature show that several genetic polymorphisms correlated with oxidative stress, inflammation, thrombosis, and blood vessel permeability are associated to SSNHL predisposition and development. 10,12,20,24,28,36,37,40,41 On the basis of this evidence, it could be hypothesized that genetic factors could play a role in maintaining the delicate balance between ROS and antioxidants, pro-inflammatory and anti-inflammatory factors, proaggregants, and antiaggregants; since the balance among these factors is important for the inner ear homeostasis, their disruption could be a factor contributing to the ISSNHL onset. Furthermore, a possible link between SSNHL and major cardiovascular diseases, such as stroke and myocardial infarction, has been previously highlighted.…”
Section: Discussionmentioning
confidence: 99%
“…Endothelial nitric oxide synthase (eNOS) produces nitric oxide (NO) inducing a vasodilation of the smooth muscle cells; the eNOS p.Glu298Asp single-nucleotide polymorphism is correlated to cardiovascular diseases. 22,23 Yazdani et al 24 found a significant association between eNOS and SSNHL in a casecontrol study, suggesting that NO plays a crucial role in cochlear neurotoxicity.…”
Section: Genetic Polymorphisms and Inner Ear Microvascular Disease And/or Endothelial Dysfunctionmentioning
confidence: 99%
“…The study subjects were categorized into two groups according to the cut-off level of dyslipidemia for each lipid component recommended by the Korean society of lipid and atherosclerosis [ 15 ]: TC ≥200 mg/dL, TG ≥150 mg/dL, HDL-C for male ≤40 mg/dL and for female ≤50 mg/dL, and LDL-C ≥130 mg/dL. To investigate the association of serum lipid levels and HL, study subjects were classified into four groups according to the quartile distribution of each lipid profile.…”
Section: Methodsmentioning
confidence: 99%